GWPH News and Press, GW Pharmaceuticals Plc From 03/16/20

The coronavirus pandemic has sent cannabis stocks and the markets as a whole into freefall over the past few weeks. And while that's unnerving for investors who have seen nothing but red, it's also a great buying opportunity with many stocks trading around all-time lows. There are a couple of c...

Coronavirus for the short term has most every country on lockdown. In the U.S. major cities are seeing schools closed, businesses shifting workers to home, restaurants and bars shut and major interruptions in international travel and cruising. Globally there are 145,369 cases and 5,429 reporte...

Smart marketers will advise to hold the rudder steady during surprise setbacks in the marketplace, and CBD Unlimited, Inc., is maintaining the innovative and aggressive marketing strategy that has already grown its business organically and by acquisition. It markets CBD product through a broad...

Editors' Note: This is the transcript version of the podcast we published last Wednesday with Oren Benoff. Please note that due to time and audio constraints, transcription may not be perfect. We encourage you to listen to the podcast, embedded below, if you need any clarification. We...

The coronavirus may be triggering Dow 10% stock drops and sports cancellations, but firms such as CBD Unlimited, Inc. ( OTC PINK: EDXC ), a provider of phytonutrient-based food and nutritional products, maintain aggressive M&A growth by recently acquiring Kush, Inc. Kush is a New York-ba...

Coronavirus yesterday (March 12, 2020) saw a 10% drop in the Dow stocks on Wall Street, sport league cancellations, school closings — even Disneyland in California will be shut. Thus far, there are 128,863 global cases of coronavirus — from Tom Hanks to the wife of the Canadian p...

GW Pharmaceuticals (NASDAQ: GWPH ) has filed a supplemental marketing application in Europe seeking approval to use Epidiolex (cannabidiol) to treat seizures associated with Tuberous Sclerosis Complex , a rare inherited disorder characterized by non-cancerous tumors in the brain (causing ...

LONDON, March 13, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”, “the Company” or “the Group”), a world leader in discovering, developing and commercialising cannabinoid prescription medicines, today announces the submission o...

On Feb. 27, shares of Zogenix (NASDAQ:ZGNX) , a California-based pharmaceutical company, slid by about 9%. This drop came on the heels of the company's announcement that the U.S. Food and Drug Administration (FDA) extended the review period for Fintepla, a product for which Zogenix submitted ...

All those predictions for the CBD market hitting $2.1 billion in 2020 by hemp business publications may have been right earlier, but the coronavirus and its global impact has changed everything. CBD may still be a growth and consolidation industry, but the coronavirus has changed daily activit...